{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Malabsorption+Syndromes&page=2", "query": { "condition": "Malabsorption Syndromes", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Malabsorption+Syndromes&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-10T06:03:26.856Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01113619", "title": "Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lactose Intolerance" ], "interventions": [ { "name": "RP-G28 or placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ritter Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 61, "start_date": "2011-04", "completion_date": "2011-12", "has_results": false, "last_update_posted_date": "2011-12-08", "last_synced_at": "2026-06-10T06:03:26.856Z", "location_count": 2, "location_summary": "Honolulu, Hawaii • Dallas, Texas", "locations": [ { "city": "Honolulu", "state": "Hawaii" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01113619" }, { "nct_id": "NCT01931644", "title": "At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "All Diagnosed Health Conditions", "ADD/ADHD", "Alopecia Areata", "Ankylosing Spondylitis", "Asthma", "Atopic Dermatitis Eczema", "Beta Thalassemia", "Bipolar Disorder", "Breast Cancer", "Celiac Disease", "Cervical Cancer", "Chronic Inflammatory Demyelinating Polyneuropathy", "Chronic Kidney Diseases", "Chronic Obstructive Pulmonary Disease", "Colon Cancer", "Colorectal Cancer", "Crohn's Disease", "Cystic Fibrosis", "Depression", "Diabetes Mellitus", "Duchenne Muscular Dystrophy", "Endometriosis", "Epilepsy", "Facioscapulohumeral Muscular Dystrophy", "G6PD Deficiency", "General Anxiety Disorder", "Hepatitis B", "Hereditary Hemorrhagic Telangiectasia", "HIV/AIDS", "Human Papilloma Virus", "Huntington's Disease", "Idiopathic Thrombocytopenic Purpura", "Insomnia", "Kidney Cancer", "Leukemia", "Lung Cancer", "Lupus Nephritis", "Lymphoma", "Melanoma", "Multiple Myeloma", "Multiple Sclerosis", "Myositis", "Myotonic Dystrophy", "Ovarian Cancer", "Pancreatic Cancer", "Parkinson's Disease", "Polycystic Kidney Diseases", "Prostate Cancer", "Psoriasis", "Psoriatic Arthritis", "Rosacea", "Scleroderma", "Sickle Cell Anemia", "Sickle Cell Trait", "Sjogren's Syndrome", "Skin Cancer", "Spinal Muscular Atrophy", "Systemic Lupus Erythematosus", "Thrombotic Thrombocytopenic Purpura", "Trisomy 21", "Ulcerative Colitis" ], "interventions": [], "intervention_types": [], "sponsor": "Sanguine Biosciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 17667, "start_date": "2013-07", "completion_date": "2024-04", "has_results": false, "last_update_posted_date": "2024-04-18", "last_synced_at": "2026-06-10T06:03:26.856Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01931644" }, { "nct_id": "NCT01576003", "title": "Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bloodstream Infections", "Short Bowel Syndrome", "Development", "Nutrition", "Biological Markers" ], "interventions": [ { "name": "Glutamine", "type": "DRUG" }, { "name": "L-alanine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Months", "sex": "ALL", "summary": "6 Weeks to 12 Months" }, "enrollment_count": 10, "start_date": "2012-04", "completion_date": "2015-06", "has_results": true, "last_update_posted_date": "2020-06-11", "last_synced_at": "2026-06-10T06:03:26.856Z", "location_count": 2, "location_summary": "Ann Arbor, Michigan • Cincinnati, Ohio", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01576003" }, { "nct_id": "NCT01560169", "title": "Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Celiac Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Alvine Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 110, "start_date": "2012-03", "completion_date": "2013-09", "has_results": false, "last_update_posted_date": "2013-10-10", "last_synced_at": "2026-06-10T06:03:26.856Z", "location_count": 9, "location_summary": "La Jolla, California • San Diego, California • Aurora, Colorado + 6 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01560169" }, { "nct_id": "NCT05309330", "title": "Virtual Celiac Symptoms Study in Adults and Teenagers", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Celiac Disease" ], "interventions": [ { "name": "No Intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 480, "start_date": "2022-08-16", "completion_date": "2023-03-04", "has_results": false, "last_update_posted_date": "2023-03-10", "last_synced_at": "2026-06-10T06:03:26.856Z", "location_count": 1, "location_summary": "Lexington, Massachusetts", "locations": [ { "city": "Lexington", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05309330" }, { "nct_id": "NCT04054544", "title": "Gluten Challenge Study in Celiac Disease Participants (MK-0000-402)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Celiac Disease" ], "interventions": [ { "name": "Gluten powder 4g", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 18, "start_date": "2020-08-28", "completion_date": "2021-06-23", "has_results": true, "last_update_posted_date": "2023-03-06", "last_synced_at": "2026-06-10T06:03:26.856Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04054544" }, { "nct_id": "NCT02849704", "title": "Fat Malabsorption in Chronic Pancreatitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Pancreatitis" ], "interventions": [ { "name": "Creon36™", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "30 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "30 Years to 70 Years" }, "enrollment_count": 48, "start_date": "2016-10-13", "completion_date": "2017-11-01", "has_results": true, "last_update_posted_date": "2019-05-03", "last_synced_at": "2026-06-10T06:03:26.856Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02849704" }, { "nct_id": "NCT04573959", "title": "Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Intestinal Disease", "Inflammatory Bowel Diseases", "Crohn Disease", "Ulcer", "Celiac Disease" ], "interventions": [ { "name": "SV-3 Capsule Endoscopy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Capso Vision, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 84, "start_date": "2015-10-01", "completion_date": "2020-06-11", "has_results": false, "last_update_posted_date": "2020-10-05", "last_synced_at": "2026-06-10T06:03:26.856Z", "location_count": 1, "location_summary": "Saratoga, California", "locations": [ { "city": "Saratoga", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04573959" }, { "nct_id": "NCT01952080", "title": "A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Short Bowel Syndrome" ], "interventions": [ { "name": "teduglutide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "17 Years", "sex": "ALL", "summary": "1 Year to 17 Years" }, "enrollment_count": 42, "start_date": "2013-11-14", "completion_date": "2015-01-09", "has_results": true, "last_update_posted_date": "2021-06-09", "last_synced_at": "2026-06-10T06:03:26.856Z", "location_count": 18, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01952080" }, { "nct_id": "NCT04677699", "title": "Combined Antibody Screening for Celiac and Diabetes Evaluation", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Type 1 Diabetes", "Celiac Disease" ], "interventions": [ { "name": "Combined Risk Score", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Pacific Northwest Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Day", "maximum_age": "7 Years", "sex": "ALL", "summary": "1 Day to 7 Years" }, "enrollment_count": 64410, "start_date": "2020-12", "completion_date": "2026-06", "has_results": false, "last_update_posted_date": "2020-12-21", "last_synced_at": "2026-06-10T06:03:26.856Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT04677699" } ] }